MBCs of methicillin, oxacillin, penicillin G, cephalothin, vancomycin, and gentamicin were determined by a standard broth macrodilution technique for 101 clinical isolates of methicillin-susceptible Staphylococcus aureus. Increased killing (more than 99.9%) was observed after 48 versus 24 h of incubation for many strains, and cross tolerance to antimicrobial bactericidal activity (less than 99.9% killing) was frequently observed among antimicrobial agents. However, these in vitro measurements of bactericidal activity against S. aureus were not reproducible.
Best and colleagues (4) described a strain of Staphylococcus aureus susceptible to oxacillin by MIC criteria but resistant to the bactericidal effect of oxacillin in killing-curve experiments. Strains tolerant to the bactericidal and lytic effects of oxacillin demonstrated oxacillin-induced inhibition of staphylococcal autolytic enzymes on the surface of the organism (3) . From these studies, Best et al. concluded that the usual bactericidal effect of oxacillin was due to the combined effect of antimicrobial interference with cell wall synthesis and destruction of cell wall by endogenous autolytic enzymes. Mayhall et al. (25) found oxacillin tolerance in 33 of 60 clinical S. aureus isolates by MBC testing and log 5-CFU/ml killing-curve experiments with stationary-growthphase inocula. Sabath et al. (33) defined "antimicrobial tolerance" as an MBC/MIC ratio of .32, after using standard techniques with log-growth-phase organisms to show cross tolerance among 28 of 63 blood culture isolates for the penicillins, cephalosporins, and vancomycin. Sabath and colleagues also confirmed impaired lysis and autolysin production in tolerant strains exposed to antimicrobial agents. Bradley et al. (5) found that 16 of 30 strains were tolerant to oxacillin and cephalothin with 0.2 to 43% of the initial log 5-cfu/ml stationary-phase inoculum surviving after 24 h of incubation in Mueller-Hinton broth. Goessens et al. (13) obtained similar results for 64 isolates, with 12.5% of the isolates showing more than 2% survivors after 24 h of incubation for a variety of antimicrobial concentrations, and termed this the tolerance percentage. Several retrospective clinical studies have suggested that the clinical response to beta-lactam therapy of antimicrobial agent-tolerant infections might be impaired (8, 17, 30) , but tolerance did not affect the response to treatment in the rabbit model of staphylococcal endocarditis (14) or the rat model of staphylococcal pyelonephritis (16) .
Numerous investigators have found the in vitro assessment of antimicrobial agent bactericidal activity against S. aureus very difficult to assess in a reproducible fashion. In vitro antimicrobial agent-induced staphylococcal killing has been reported to be influenced by the growth phase of the initial inoculum (2, 6, 20) , type of media (29, 36) , medium pH (7, 36) , beta-lactam antimicrobial agent concentration with paradoxical reduction in killing at higher concentrations (10, 35) , duration of incubation (18) , in vitro inactivation of antimicrobial agents by beta-lactamases (6, 11, 21) , emergence of drug-resistant mutants (26, 28) , carry-over of active antimicrobial agent to subcultures (12, 18, 35) , survival or organisms on the wall of test tubes above the fluid level (18, 25, 35) , freezing of test organisms before testing (24, 33) , and statistical considerations about sampling and counting survivors (27) . A recent study that controlled most of these variables was unable to demonstrate the phenomenon of in vitro tolerance (35 (9, 23) . Twenty-eight strains were susceptible to penicillin G; the remainder were penicillinase producers by the method of Rosenblatt and Neumann (31) or Lee and Komarmy (22) .
Antibiotics. Standard powders were provided by the manufacturers: sodium oxacillin and sodium methicillin (Bristol Laboratories, Syracuse, N.Y.); penicillin G, sodium cephalothin, and vancomycin hydrochloride (Eli Lilly & Co., Indianapolis, Ind.); and gentamicin sulfate (Schering Corp., Bloomfield, N.J.).
MIC/MBC testing. MICs were determined in 1 ml of Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.) in 10-ml glass test tubes with log 5-cfu/ml log-growth-phase inocula subcultured from the original isolation plates (1) . MIC endpoints were read as the lowest antimicrobial concentration producing a clear tube. All inocula were quantitated and averaged to log 5.7 cfu/ml. Clear tubes were sampled after 24 h of incubation at 35°C with a calibrated 0.01-ml loop and streaked on quadrants of a sheep blood agar plate. CFUs were counted after 18 to 24 h of incubation at 35°C, and the MBC was read as the lowest antibiotic (13, 25, 33, 37) , with cross tolerance for methicillin, oxacillin, cephalothin, penicillin G, and vancomycin but not gentamicin (25) . Killing was increased by 48 h of incubation as compared with 24 h of incubation for methicillin, oxacillin, penicillin G, cephalothin, vancomycin, and gentamicin. Increased killing with longer incubation periods of incubation has been reported previously (18, 33) . Our most significant finding was the lack of reproducibility of MBC measurements when a standard strain was used. This lack of reproducibility has been noted by others and has been attributed to the freezing of strains (24, 33) and the shaking of tubes (18, 25, 35) . A recent, carefully done study trying to eliminate technical aspects that could lead to persistance of organisms failed to demonstrate antimicrobial tolerance in strains previously labeled as tolerant (35) .
Editorials discussing staphylococcal antimicrobial tolerance have failed to stress the irreproducibility of this measurement (19, 32) . From numerous and conflicting studies of this subject, a number of observations have emerged that may result in future agreement for a standard technique: (i) stationary-phase organisms are less susceptible to the bactericidal action of beta-lactam antimicrobial agents (2, 15) , (ii) a reduction in killing occurs at higher concentrations of beta-lactam antimicrobial agents (10, 35) (iii) measures to reduce the survival of staphylococci above the fluid meniscus will improve apparent killing (18, 29, 35) , (iv) inactivation of antimicrobial agents in vitro by staphylococcal betalactamases impairs killing by some beta-lactam agents (6, 11, 21) , and (v) the emergence of antimicrobial agent-resistant mutants is a rare event seen mainly with gentamicin and rifampin (26, 28) . Taylor and colleagues (35) 
